ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ENSTILAR
Psoriasis
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ENSTILAR Rx

Generic Name and Formulations:
Calcipotriene (as hydrate) 0.005% + betamethasone dipropionate 0.064%; foam.

Company:
LEO Pharma Inc.

Therapeutic Use:

Indications for ENSTILAR:

Plaque psoriasis.

Adult:

Apply to affected areas once daily for up to 4 weeks; discontinue when control is achieved. ≥18yrs: max 60g every 4 days. Do not occlude.

Children:

<18yrs: not studied.

Warnings/Precautions:

Discontinue if hypercalcemia or hypercalciuria develop; may resume once calcium metabolism has normalized. Discontinue or reduce dose or potency if HPA axis suppression, Cushing's syndrome, hyperglycemia, or irritation occurs. Do not use on face, axillae, or groin, or if atrophy is present at treatment site. Avoid eyes, sun, UV light (eg, phototherapy). Flammable. Allergic contact dermatitis. Pregnancy (Cat.C). Nursing mothers.

Interactions:

Systemic absorption potentiated by other corticosteroids.

Pharmacological Class:

Vit. D3 derivative + topical steroid.

Adverse Reactions:

Application site irritation and pruritus, folliculitis, skin hypopigmentation, hypercalcemia, urticaria, psoriasis exacerbation.

How Supplied:

Foam (60g)—1, 2

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs